Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R.
Cancer Treatment Reports 66(7): 1687-1688
1982
ISSN/ISBN: 0361-5960 PMID: 7093975 Document Number: 194374
Document emailed within 1 workday
Related Documents
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Davidson, K.L.; Devaney, M.B.; Tighe, J.E.; Rogers, S.Y.; Dunlop, D.J.; Mackie, M.J.; Thomas, R.V.; Johnson, P.R.E. 2003: A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study Haematologica 88(12): 1366-1371
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Coltman, C.A.; Dixon, D.O. 1982: Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup Cancer Treatment Reports 66(4): 1023-1033
Boros, L.; Tsiatis, A.A.; Neiman, R.S.; Mann, R.B.; Glick, J.H. 1986: Phase Ii Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma Cancer Treatment Reports 70(7): 917-918
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Behringer, K.; Wildt, L.; Mueller, H.; Mattle, V.; Ganitis, P.; van den Hoonaard, B.; Ott, H.W.; Hofer, S.; Pluetschow, A.; Diehl, V.; Engert, A.; Borchmann, P. 2010: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase Ii trial from the German Hodgkin Study Group Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(10): 2052-2060
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Stehman, F.B.; Blessing, J.A.; Delgado, G.; Louka, M. 1983: Phase Ii evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study Cancer Treatment Reports 67(7-8): 737-738
Hilgers, R.D.; Von Hoff, D.D.; Stephens, R.L.; Boutselis, J.G.; Rivkin, S.E. 1985: Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study Cancer Treatment Reports 69(11): 1329-1330
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Oishi, N.; Berenberg, J.; Blumenstein, B.A.; Johnson, K.; Rivkin, S.E.; Bukowski, R.M.; O'Bryan, R.M.; Stephens, R.L.; Quagliana, J.; Saiers, J.H. 1987: Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1307-1308
Goodwin, W.; Stephens, R.; McCracken, J.D.; Groppe, C. 1981: Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treatment Reports 65(3-4): 359